(Q30447195)

21 June 2017

title

Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down". (English)

1 reference

21 June 2017

1 reference

Steven M Koenig

1

1 reference

21 June 2017

Nancy Ostrom

2

1 reference

21 June 2017

David Pearlman

3

1 reference

21 June 2017

Kelli Waitkus-Edwards

4

1 reference

21 June 2017

Steven Yancey

5

1 reference

21 June 2017

Barbara A Prillaman

6

1 reference

21 June 2017

Paul Dorinsky

7

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

21 June 2017

1 reference

21 June 2017

volume

45

1 reference

21 June 2017

issue

8

1 reference

21 June 2017

page(s)

681-687

1 reference

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Potential masking effects of salmeterol on airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

Salmeterol/Fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802168695

10.1080/02770900802168695

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference